Search

888 443 3311
    Clarient facebook  Clarient Twitter

PATHSiTE LOG IN
PATHSiTE® is our web-based solution with applications to help you view and manage your cases.

Learn more PATHSiTE Log In

Is my cancer different
 

MultiOmyx, Advanced, Multi-Molecular, Multiplexing Methodology

We are pleased to introduce an aid to a pathologist’s diagnosis. The first Hodgkin Lymphoma Profile on a single slide…featuring the new proprietary platform, MultiOmyx, a multi-molecular, multiplexed, in-context tissue assessment platform to help dismantle secrets about cancer. Learn more

Clarient Insight™Dx Mammostrat™

Reduce your patient’s anxiety with test results available in days… not weeks. Clarient’s InsightDx Mammostrat provides important information independent of proliferation and grade to aid physicians in making appropriate and earlier treatment decisions in order to determine which patients are most likely to recur from breast cancer. Learn more

ALK-BreakAPart
ALK-BreakAPart


The Vysis ALK Break Apart FISH Probe Kit Intended Use1:


The Vysis ALK Break Apart FISH Probe Kit is a quantitative test to detect rearrangements involving the ALK gene via fluorescence in situ hybridization (FISH) in formalin-fixed paraffin-embedded (FFPE) non-small cell lung cancer (NSCLC) tissue specimens to aid in identifying those patients eligible for treatment with XALKORI (crizotinib). This test is for prescription use only.”

For more information, please contact your local sales representative or call Clarient Client Services at 1-888-443-3311.

References:

  1. Vysis ALK Break Apart FISH Probe Kit. Package Insert. Des Plaines, IL: Abbott Molecular Inc.: 2011.

BCR-ABL1, Major (p210), International Scale (IS), Quantitative PCR

 

MultiOmyx - ASH

Lawrence M. Weiss — ASH - 2013 Video